Literature DB >> 966453

The role of volume contraction in the hypocalciuric action of chlorothiazide.

N Breslau, A M Moses, I M Weiner.   

Abstract

Thiazide-induced hypocalciuria usually requires two to four days of drug treatment for its full expression. The present experiments were designed to test the possibility that an immediate hypocalciuria could be produced in subjects whose extracellular volumes were already contracted. In previously untreated subjects, chlorothiazide (2 g/day) did not produce hypocalciuria on the first day of treatment. Hypocalciuria occurred on the second day and was somewhat enhanced on the third and fourth days of treatment. In subjects pretreated with furosemide (40 mg two or three times a day for two days), chlorothiazide produced hypocalciuria on the first day of its use. Under the influence of chlorothiazide, there was a strong linear correlation between the changes in the excretion of calcium and sodium. The results are consistent with the idea that chlorothiazide enhances the ratio of calcium to sodium reabsorptions and that this tendency for absolute hypocalciuria can be overridden by a large natriuretic response to the drug. Volume contraction, which minimizes the natriretic response to diuretics, allows a more immediate and pronounced hypocalciuric response to thiazides.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 966453     DOI: 10.1038/ki.1976.91

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.

Authors:  H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Distal convoluted tubule.

Authors:  James A McCormick; David H Ellison
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

Review 3.  Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.

Authors:  Faryal Mirza; Ernesto Canalis
Journal:  Eur J Endocrinol       Date:  2015-05-13       Impact factor: 6.664

Review 4.  The mechanism of hypocalciuria with NaCl cotransporter inhibition.

Authors:  Robert F Reilly; Chou-Long Huang
Journal:  Nat Rev Nephrol       Date:  2011-09-27       Impact factor: 28.314

Review 5.  Renal handling of calcium and phosphate.

Authors:  F Lang
Journal:  Klin Wochenschr       Date:  1980-10-01

6.  Thiazides diuretics in the treatment of nephrolithiasis: are we using them in an evidence-based fashion?

Authors:  Rebecca Vigen; Rick A Weideman; Robert F Reilly
Journal:  Int Urol Nephrol       Date:  2010-08-25       Impact factor: 2.370

7.  Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats.

Authors:  David A Bushinsky; Thomas Willett; John R Asplin; Christopher Culbertson; Sara P Y Che; Marc Grynpas
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

Review 8.  The loop diuretic torasemide in chronic renal failure. Pharmacokinetics and pharmacodynamics.

Authors:  H Knauf; H Spahn; E Mutschler
Journal:  Drugs       Date:  1991       Impact factor: 9.546

9.  The relation between bone and stone formation.

Authors:  Nancy S Krieger; David A Bushinsky
Journal:  Calcif Tissue Int       Date:  2012-12-18       Impact factor: 4.333

10.  Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney function.

Authors:  H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.